A GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa's largest ever clinical trial
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment